Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-176,000
Closed -$14.8M 2391
2025
Q3
$14.8M Buy
+176,000
New +$14.5M 0.08% 255
2024
Q2
Sell
-50,000
Closed -$6.6M 2419
2024
Q1
$6.6M Buy
+50,000
New +$6.16M 0.04% 537
2021
Q3
Sell
-200,000
Closed -$15.6M 2353
2021
Q2
$15.6M Buy
+200,000
New +$14.9M 0.17% 179

Other funds holding MRK

Steve Schonfeld's MRK Position: Q2 2026 in Review

Steve Schonfeld reduced its Merck (MRK) stake by 55% in Q2 2026, selling an estimated $2.24M and leaving 15,528 shares worth $2M. The position accounts for 0.01% of the portfolio, ranked #1071.

Steve Schonfeld first reported a position in MRK in Q2 2016 and has held it in 36 quarters since. The position peaked at $50.9M in Q1 2025. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Steve Schonfeld held 15,528 shares of Merck worth $2M as of Q2 2026.
  • Steve Schonfeld sold 19,166 Merck shares in Q2 2026, an estimated $2.24M.
  • Merck made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1071 holding.
  • Steve Schonfeld first reported a position in Merck in Q2 2016 and has held it in 36 quarters since.
  • Steve Schonfeld's Merck position peaked at $50.9M in Q1 2025.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.